A plan to maintain optimal blood product labeling is an essential part of disaster preparedness.
2 min read |Members Only |Insider's View
Transfusion leaders discuss how Canada will move forward to ensure continued vein-to-vein safety and ongoing monitoring following the end of the country's historic hemovigilance program.
11 min read |Members Only |Feature
In this month's President's message, Jose Cancelas, MD, PhD, CABP, discusses safeguarding the blood system, ensuring both safety and sufficiency in the face of evolving threats.
2 min read |Open Access |President’s Message
A pioneer in blood safety during the HIV/AIDS epidemic, Edgar Engleman, MD, shaped screening efforts and laid the groundwork for cellular therapies used in cancer treatment.
9 min read |Open Access |Feature
Tracy Antonelli shares her journey living with thalassemia and adopting three daughters from China with the same rare blood disorder.
7 min read |Open Access |Feature
Of Note: News stories from the field.
9 min read |Members Only |Of Note
Experts examine lessons learned from the history of emerging infectious diseases and how the field can prepare now to ensure a safe and sufficient blood supply during the next emerging pathogen event.
7 min read |Members Only |Feature
José Arnulfo Pérez-Carrillo discusses his efforts to advance blood safety in Colombia and the key to translating hemovigilance data into meaningful change.
7 min read |Open Access |White Coats
Antonella Nai discusses the potential impact of her AABB-Foundation supported project and how it may shape future therapies for anemia in transfusion medicine and biotherapies.
5 min read |Open Access |AABB Foundation: Shaping the Industry
If you understand how exercise affects your brain and emotions, you can use it as a practical tool to improve your daily life.
5 min read |Members Only |Be Well
Emily Wilson shares her inspiration for becoming a CABP and the importance of maintaining certification.
2 min read |Open Access |High Priority
"I share AABB’s mission and vision to improve the lives of individuals by making transfusions and biotherapies safe, available and effective throughout the world."
2 min read |Members Only |Membership Focus
Lillian Maria de Castilho, PhD, discusses her work advancing transfusion medicine and biotherapies through innovation in blood group genetics, collaboration and mentorship.
8 min read |Open Access |Feature
Nabajyoti Choudhury, MBBS, PhD, MBA, reflects on his decades-long effort to strengthen blood safety and quality systems across Asia.
7 min read |Open Access |Feature
The Blood D.E.S.E.R.T. Coalition is focusing on four strategies to address the disparities associated with blood deserts.
8 min read |Open Access |Feature
A hands-on workshop at the AfSBT Congress highlights global efforts to improve access to safer transfusion practices.
9 min read |Open Access |Feature
In this month's President's message, Jose Cancelas, MD, PhD, CABP, discusses advancing a global framework that integrates transfusion medicine and biotherapies through evidence-based standards, workforce development and strategic partnerships.
2 min read |Open Access |President’s Message
Throughout Latin America, the conversation about quality in blood and biotherapies is shifting from isolated achievements to systems that can be replicated, audited and sustained.
5 min read |Open Access |High Priority
Of Note: News stories from the field.
5 min read |Of Note
Carlos Ferrari Rebolledo, MSc, MT, discusses his career path, the challenges of achieving AABB accreditation and the evolving landscape of cellular therapies in Chile.
7 min read |Members Only |White Coats
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
